Zoetis (ZTS) EBIT Margin (2012 - 2026)
Zoetis' EBIT Margin was 33.91% in Q2 2026, down 3.68 percentage points from 37.59% a year earlier but up 3.10 percentage points from the prior quarter.
Zoetis (ZTS) EBIT Margin (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zoetis' EBIT Margin was 23.54% through Jun 30, 2026, down 1.91 percentage points year-over-year; for FY2025, it was 36.32%, up 0.31 percentage points from FY2024.
- EBIT Margin shows a five-year change of +2.67 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was 36.01% in FY2024 (+2.43 pp), 33.58% in FY2023 (-0.39 pp), 33.97% in FY2022 (+0.88 pp) and 33.09% in FY2021 (-0.56 pp).
- Quarterly EBIT Margin has moved between -10.02% (Q4 2021) and 37.59% (Q2 2025) over five years.
- Compared with a year earlier, EBIT Margin was higher in five of the last eight quarters, with an average year-over-year change of -0.45 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q1 2024 (a gain of 3.82 percentage points); the worst was Q1 2026 (a drop of 4.63 percentage points).
- Per Business Quant data, ZTS's EBIT Margin in the three quarters before Q2 2026 was 30.81% (Q1 2026), -8.09% (Q4 2025) and 37.46% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 28.37% |
| 10 | Zoetis | 33.38 Bn | 25.23 Bn | 1.80 Bn | 38.61% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.61% |
| Mar 31, 2026 | 36.74% |
| Dec 31, 2025 | 35.19% |
| Sep 30, 2025 | 40.17% |
| Jun 30, 2025 | 40.42% |
| Mar 31, 2025 | 38.40% |
| Dec 31, 2024 | 34.40% |
| Sep 30, 2024 | 39.78% |
| Jun 30, 2024 | 38.08% |
| Mar 31, 2024 | 38.08% |
| Dec 31, 2023 | 33.35% |
| Sep 30, 2023 | 38.12% |
| Jun 30, 2023 | 39.59% |
| Mar 31, 2023 | 37.20% |
| Dec 31, 2022 | 35.44% |
| Sep 30, 2022 | 37.66% |
| Jun 30, 2022 | 37.13% |
| Mar 31, 2022 | 41.69% |
| Dec 31, 2021 | 32.13% |
| Sep 30, 2021 | 38.14% |
Zoetis EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZTS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ZTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();